Concepedia

Natalia Gankina

NG

3

Publications

445

Citations

3

H-Index

2017

Active since

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Natalia Gankina is an author at Assistance Publique – Hôpitaux de Paris specializing in virology, medicine, and hepatitis.

Top concepts

Publications per year

2017–2023

3

Publications

3

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

, , +14

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 64 citations

, , +10

Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection

Natalia Gankina, Viacheslav Morozov, Kathryn Kersey et al. · Clinical Drug Investigation · 2017 · 10 citations

, , +8

Rows per page

1–3 of 3